Parodies of Christian Wandering in Luis Buñuel’s Films

This essay investigates parodic profanations of Christian peregrination in three films by Luis Buñuel: Nazarín (1959), Simón del desierto (1965), and La Voie lactée (1969). Proceeding from Jesus Christ, Simeon the stylite, and Santiago de Compostela, these movies focus on two central figures of religious wandering, the itinerant preacher and the pilgrim, whose devout essence is subverted in manifold ways ranging from heresy and eroticism to social failure and homelessness. In this connection, walking is distinguished from artificial and supernatural forms of locomotion, but at the same time connected to surrealist time travels and narrative digressions. The article traces how the motif of walking is related to the movies’ formal features and carefully examines the intertextual relations that tie the films not only to each other, but also to the picaresque novel as an important model of profanation

Measurements of left ventricular myocardial longitudinal systolic displacement using spectral and colour tissue Doppler: time for a reassessment?

<p>Abstract</p> <p>Background</p> <p>Echocardiographic measurements of left ventricular (LV) myocardial displacement may produce different results depending on the choice of employed modality and subjective adjustments during data acquisition and analysis.</p> <p>Methods</p> <p>In this study, left ventricular longitudinal systolic displacement was quantified in 57 patients (31 women and 26 men, 50 ± 16 years) using colour (colour TD) and spectral tissue Doppler (spectral TD) before and after temporal filtering (30 to 70 milliseconds in 20-millisecond steps) and changed offline gain saturation (0%, 50% and 100%), respectively. The results were compared with those obtained with anatomic M-mode.</p> <p>Results</p> <p>Whereas only minor differences occurred between the results of colour TD and anatomic M-mode measurements, spectral TD significantly overestimated the results obtained with both these methods. However, the limits of agreement between the results produced by all three studied methods were not clinically acceptable in any of the cases. The spectral TD displacement values increased along with increasing offline gain saturation whereas the effect of temporal filtering on colour Doppler measurements was insignificant.</p> <p>Conclusion</p> <p>Measurements of LV myocardial longitudinal displacement employing spectral TD, colour TD or anatomic M-mode produce different results, thus discouraging interchangeable use of these modalities. Whereas the results of spectral TD measurements can be significantly altered by changing offline gain setting, the effect of temporal filtering on colour TD measurements is insignificant, a fact that increases clinical practicality of the latter method.</p

Impact of Particle Size Distribution on Performance of Lithium‐Ion Batteries

This work reveals the impact of particle size distribution of spherical graphite active material on negative electrodes in lithium‐ion batteries. Basically all important performance parameters, i. e. charge/discharge characteristics, capacity, coulombic and energy efficiencies, cycling stability and C‐rate capability are shown to be affected by distribution shapes. A narrow distribution with smaller particles results in better cell performance than broader and coarser distributions. However, particle size reduction has a limitation as extremely small particles show negative effect in performance. More critically, independent of the particle size distribution, the existence of coarse particles are found to promote lithium plating, which lowers cell performance and threatens the safety of battery operation. Furthermore, impedance analysis and cycling stability show huge differences for different electrodes. Our study shows that a better understanding of the influence of particle size distribution is an important base to engineer electrodes with higher C‐rate capability, higher performance, and lower safety risk due to lithium plating

Revealing the Impact of Particle Size Distribution on Ageing of Lithium‐Ion Batteries with Frequency Response Analysis

In-depth analyses, including discharge behaviour, electrochemical impedance analysis, and for the first time, nonlinear frequency response analysis, are conducted on the ageing of negative electrodes with varying particle size distribution. The electrode-resolved analysis is used to distinguish the kinetic and transport losses at the respective electrodes. For fine to medium-sized particles at the negative electrode, ageing impacts are found more on the positive electrode: the impedance and nonlinear responses increase, suggesting that the charge transfer process at the positive electrode is worsened. Meanwhile, for coarse and broad negative particles, the impedance and nonlinear responses at negative electrodes decrease due to improved kinetics from micro-cracking. The second harmonic reveals a change in the nature of the charge transfer during ageing: the charge transfer process at the positive electrode becomes asymmetric for fine and medium-sized negative particles. Vice versa, the charge transfer process at the negative electrode becomes symmetric for coarse and broad negative particles

Non-targeted urine metabolomics and associations with prevalent and incident type 2 diabetes

Better risk prediction and new molecular targets are key priorities in type 2 diabetes (T2D) research. Little is known about the role of the urine metabolome in predicting the risk of T2D. We aimed to use non-targeted urine metabolomics to discover biomarkers and improve risk prediction for T2D. Urine samples from two community cohorts of 1,424 adults were analyzed by ultra-performance liquid chromatography/mass spectrometry (UPLC-MS). In a discovery/replication design, three out of 62 annotated metabolites were associated with prevalent T2D, notably lower urine levels of 3-hydroxyundecanoyl-carnitine. In participants without diabetes at baseline, LASSO regression in the training set selected six metabolites that improved prediction of T2D beyond established risk factors risk over up to 12 years' follow-up in the test sample, from C-statistic 0.866 to 0.892. Our results in one of the largest non-targeted urinary metabolomics study to date demonstrate the role of the urine metabolome in identifying at-risk persons for T2D and suggest urine 3-hydroxyundecanoyl-carnitine as a biomarker candidate.Peer reviewe

Plasma calcitonin gene‐related peptide (CGRP) in migraine and endometriosis during the menstrual cycle

Objective: Migraine, endometriosis, and the comorbidity of both are frequent pain disorders of special relevance for women. The neuropeptide calcitonin gene-related peptide (CGRP) is critically involved in migraine, and circumstantial evidence suggests a role in endometriosis. We assessed CGRP levels at different times of menstrual cycle in four groups: healthy women, women with migraine or endometriosis and with the comorbidity of both. Methods: Women with episodic migraine and women with a histologically confirmed endometriosis were recruited from specialized centers. For CGRP determination with a commercial enzyme immunoassay kit, cubital vein blood samples were collected on menstrual cycle day 2 ± 2 (during menstruation) and on day 15 ± 2 (periovulatory period). The primary endpoint of the study was the absolute difference of CGRP plasma levels between the menstrual and the periovulatory phase of all study groups. Groups were compared using nonparametric test procedures. Results: A total of 124 women were included in the study. The change of CGRP plasma levels between menstruation and the periovulatory period was different between groups (p = 0.007). Women with comorbid migraine and endometriosis showed an increase of CGRP in the menstrual phase of +6.32 (interquartile range, IQR −3.64–13.60) compared to the periovulatory time, while healthy controls had a decrease of −10.14 (−22.54–0.91, p = 0.004). CGRP levels were different in the periovulatory phase among groups (p = 0.008), with highest values in healthy controls. Interpretation: CGRP levels change significantly during the menstrual cycle. Different patterns in women with the comorbidity point to a deviant regulation of CGRP release

Glucose challenge metabolomics implicates medium-chain acylcarnitines in insulin resistance

Insulin resistance (IR) predisposes to type 2 diabetes and cardiovascular disease but its causes are incompletely understood. Metabolic challenges like the oral glucose tolerance test (OGTT) can reveal pathogenic mechanisms. We aimed to discover associations of IR with metabolite trajectories during OGTT. In 470 non-diabetic men (age 70.6 ± 0.6 years), plasma samples obtained at 0, 30 and 120 minutes during an OGTT were analyzed by untargeted liquid chromatography-mass spectrometry metabolomics. IR was assessed with the hyperinsulinemic-euglycemic clamp method. We applied age-adjusted linear regression to identify metabolites whose concentration change was related to IR. Nine trajectories, including monounsaturated fatty acids, lysophosphatidylethanolamines and a bile acid, were significantly associated with IR, with the strongest associations observed for medium-chain acylcarnitines C10 and C12, and no associations with L-carnitine or C2-, C8-, C14- or C16-carnitine. Concentrations of C10- and C12-carnitine decreased during OGTT with a blunted decline in participants with worse insulin resistance. Associations persisted after adjustment for obesity, fasting insulin and fasting glucose. In mouse 3T3-L1 adipocytes exposed to different acylcarnitines, we observed blunted insulin-stimulated glucose uptake after treatment with C10- or C12-carnitine. In conclusion, our results identify medium-chain acylcarnitines as possible contributors to IR

Mutation update and genotype-phenotype correlations of novel and previously described mutations in TPM2 and TPM3 causing congenital myopathies

Mutations affecting skeletal muscle isoforms of the tropomyosin genes may cause nemaline myopathy, cap myopathy, core-rod myopathy, congenital fiber-type disproportion, distal arthrogryposes, and Escobar syndrome. We correlate the clinical picture of these diseases with novel (19) and previously reported (31) mutations of the TPM2 and TPM3 genes. Included are altogether 93 families: 53 with TPM2 mutations and 40 with TPM3 mutations. Thirty distinct pathogenic variants of TPM2 and 20 of TPM3 have been published or listed in the Leiden Open Variant Database (http://www.dmd.nl/). Most are heterozygous changes associated with autosomal-dominant disease. Patients with TPM2 mutations tended to present with milder symptoms than those with TPM3 mutations, DA being present only in the TPM2 group. Previous studies have shown that five of the mutations in TPM2 and one in TPM3 cause increased Ca2+ sensitivity resulting in a hypercontractile molecular phenotype. Patients with hypercontractile phenotype more often had contractures of the limb joints (18/19) and jaw (6/19) than those with nonhypercontractile ones (2/22 and 1/22), whereas patients with the non-hypercontractile molecular phenotype more often (19/22) had axial contractures than the hypercontractile group (7/19). Our in silico predictions show that most mutations affect tropomyosin–actin association or tropomyosin head-to-tail binding